87 related articles for article (PubMed ID: 15500005)
1. Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer.
Wang YY; Kuhajda FP; Li J; Finch TT; Cheng P; Koh C; Li T; Sokoll LJ; Chan DW
J Exp Ther Oncol; 2004 Jul; 4(2):101-10. PubMed ID: 15500005
[TBL] [Abstract][Full Text] [Related]
2. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
3. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells.
Bandyopadhyay S; Zhan R; Wang Y; Pai SK; Hirota S; Hosobe S; Takano Y; Saito K; Furuta E; Iiizumi M; Mohinta S; Watabe M; Chalfant C; Watabe K
Cancer Res; 2006 Jun; 66(11):5934-40. PubMed ID: 16740734
[TBL] [Abstract][Full Text] [Related]
5. [Expression of epidermal fatty acid-binding protein and fatty acid synthase in infiltrating ductal breast carcinoma].
Li H; Lü Q; Xue H; Dong LH; Saima N; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):381-4. PubMed ID: 18359695
[TBL] [Abstract][Full Text] [Related]
6. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
7. MRNA stability and overexpression of fatty acid synthase in human breast cancer cell lines.
Hunt DA; Lane HM; Zygmont ME; Dervan PA; Hennigar RA
Anticancer Res; 2007; 27(1A):27-34. PubMed ID: 17352212
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
Furuta E; Pai SK; Zhan R; Bandyopadhyay S; Watabe M; Mo YY; Hirota S; Hosobe S; Tsukada T; Miura K; Kamada S; Saito K; Iiizumi M; Liu W; Ericsson J; Watabe K
Cancer Res; 2008 Feb; 68(4):1003-11. PubMed ID: 18281474
[TBL] [Abstract][Full Text] [Related]
10. In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells.
Menendez JA; Decker JP; Lupu R
J Cell Biochem; 2005 Jan; 94(1):1-4. PubMed ID: 15523670
[TBL] [Abstract][Full Text] [Related]
11. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
Menendez JA; Vellon L; Oza BP; Lupu R
J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
[TBL] [Abstract][Full Text] [Related]
12. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
Weng MS; Ho CT; Ho YS; Lin JK
Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
[TBL] [Abstract][Full Text] [Related]
13. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.
Chajès V; Cambot M; Moreau K; Lenoir GM; Joulin V
Cancer Res; 2006 May; 66(10):5287-94. PubMed ID: 16707454
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
Menendez JA; Lupu R
Arch Immunol Ther Exp (Warsz); 2004; 52(6):414-26. PubMed ID: 15577743
[TBL] [Abstract][Full Text] [Related]
16. S14 protein in breast cancer cells: direct evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell growth.
Martel PM; Bingham CM; McGraw CJ; Baker CL; Morganelli PM; Meng ML; Armstrong JM; Moncur JT; Kinlaw WB
Exp Cell Res; 2006 Feb; 312(3):278-88. PubMed ID: 16300755
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of triclosan to fatty acid synthase from goose uropygial glands and human breast cancer cells in vitro].
Wang YQ; Lai BS; Anderson VE
Ai Zheng; 2003 Mar; 22(3):270-3. PubMed ID: 12654184
[TBL] [Abstract][Full Text] [Related]
18. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
Zhou W; Tu Y; Simpson PJ; Kuhajda FP
Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of fatty acid synthase for lung cancer treatment.
Orita H; Coulter J; Lemmon C; Tully E; Vadlamudi A; Medghalchi SM; Kuhajda FP; Gabrielson E
Clin Cancer Res; 2007 Dec; 13(23):7139-45. PubMed ID: 18056164
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex.
Notarnicola M; Altomare DF; Calvani M; Orlando A; Bifulco M; D'Attoma B; Caruso MG
Oncology; 2006; 71(5-6):327-32. PubMed ID: 17687193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]